Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Are the Key Milestones in the Gene Panel Market’s Growth Trajectory From 2025 To 2034?
In recent times, the gene panel market has seen considerable growth, with predictions estimating its rise from $2.14 billion in 2024 to $2.48 billion in 2025, marking a compound annual growth rate (CAGR) of 15.5%. Factors contributing to this growth during the historic period include the escalating instances of inherited disorders, the mounting need for genetic screening, increased research and development initiatives, a growing frequency of birth defects, and a heightened demand for superior treatment alternatives.
The market for gene panels is predicted to experience accelerated expansion in the coming years, reaching an estimated value of $4.37 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 15.3%. This anticipated rise during the forecast period is linked to a rise in chronic illnesses, an increase in cancer diagnoses, heightened awareness around genetic testing, and expanded government healthcare initiatives and expenditures. The period also expects to see major trends such as progress in gene panel technology, strategic partnerships, personalised treatments, the incorporation of artificial intelligence, and the application of sophisticated bioinformatics tools.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp
What Are the Core Market Drivers Propelling Growth in the Gene Panel Industry?
The surge in cancer cases is predicted to drive the growth of the gene panel market. Cancer, a cluster of diseases signified by uncontrolled growth and spread of abnormal cells that could harm surrounding tissues and organs, is going up. It’s due to factors such as aging populations, changes in lifestyle, environmental exposures, and advancements in detection and diagnostic technologies. Gene panels play a crucial role in managing cancer by offering comprehensive genetic testing. This helps identify variations and changes in specific genes, leading to personalized treatment plans and better results for cancer patients. For example, the World Health Organization, a Switzerland-based international organization, reported that cancer caused an estimated 9.7 million deaths in 2022, with 20 million new cases. Lung cancer presented the highest number of new cases at 2.5 million, accounting for 12.4% of all new cases, thereby topping the list of most common cancers worldwide. Hence, the escalating frequency of cancer is fueling the expansion of the gene panel market.
How Is the Gene Panel Market Segmented?
The gene panel market covered in this report is segmented –
1) By Product And Services: Test Kits, Testing Services
2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies
3) By Design: Predesigned Gene Panel, Customized Gene Panel
4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications
5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels
2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp
Which Regions Are Driving the Next Phase of the Gene Panel Market Growth?
North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Gene Panel Industry?
The gene panel market’s leading corporations are concentrating on the creation of innovative technologies, such as oncology panels. These advancements aim to improve the accuracy, efficiency, and comprehensiveness of cancer diagnosis and personalized treatment plans. Oncology panels are specialized gene panels that examine numerous cancer-linked genes to identify genetic changes and alterations. This process assists in the diagnosis, prognosis, and treatment of cancer. For example, in May 2023, Vizgen Inc., an American biotech firm, introduced the MERFISH PanCancer Pathways Panel. This panel provides a customizable solution for scientists venturing into the realm of spatial genomics. These pre-constructed panels are designed to suit various research applications, including cancer studies. They are also optimized for improved error robustness, yielding dependable and reproducible results. The panels amalgamate spatial information with gene expression data to provide a deeper understanding of tumor microenvironments and cell interactions. This process aids in more focused and personalized cancer research and therapy development. This new technology marks a significant progression in spatial biology as it allows researchers to examine complex biological systems with a higher level of detail than before.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report
How Is the Gene Panel Market Defined and What Are Its Core Parameters?
Gene panels refer to a collection of specific genes selected for testing in a single assay to assess genetic variations related to particular diseases or conditions. They are used for diagnosing genetic disorders, identifying inherited diseases, and providing personalized treatment plans by analyzing multiple genes simultaneously, often in the context of cancer, rare diseases, or other genetic conditions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21190
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model